Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ARGX Argenx Se	$39.1B	$0 100.0% of portfolio	0	Q2 2025 New
ARMP Armata Pharmaceuticals, Inc.	$89.3M	$0 100.0% of portfolio	0	Q2 2025 New
ARWR Arrowhead Pharmaceuticals, Inc.	$2.72B	$0 100.0% of portfolio	0	Q2 2025 New
ARVN Arvinas, Inc.	$420M	$0 100.0% of portfolio	0	Q2 2025 New
ASND Ascendis Pharma A/S	$11.1B	$0 100.0% of portfolio	0	Q2 2025 New
ASLN Aslan Pharmaceuticals LTD	$41.8M	$0 100.0% of portfolio	0	Q2 2025 New
ATXS Astria Therapeutics, Inc.	$98.7M	$0 100.0% of portfolio	0	Q2 2025 New
ATAI Atai Life Sciences N.V.	$760M	$0 100.0% of portfolio	0	Q2 2025 New
AVIR Atea Pharmaceuticals, Inc.	$280M	$0 100.0% of portfolio	0	Q2 2025 New
ATHA Athira Pharma, Inc.	$14.4M	$0 100.0% of portfolio	0	Q2 2025 New
ATOS Atossa Therapeutics, Inc.	$96.2M	$0 100.0% of portfolio	0	Q2 2025 New
LIFE A Tyr Pharma Inc	$53.2M	$0 100.0% of portfolio	0	Q2 2025 New
AURA Aura Biosciences, Inc.	$183M	$0 100.0% of portfolio	0	Q2 2025 New
AUPH Aurinia Pharmaceuticals Inc.	$1.66B	$0 100.0% of portfolio	0	Q2 2025 New
AUTL Autolus Therapeutics PLC	$136M	$0 100.0% of portfolio	0	Q2 2025 New
AVEO Aveo Pharmaceuticals, Inc.	$0	$0 100.0% of portfolio	0	Q2 2025 New
RNA Avidity Biosciences, Inc.	$2.43B	$0 100.0% of portfolio	0	Q2 2025 New
AXSM Axsome Therapeutics, Inc.	$5.29B	$0 100.0% of portfolio	0	Q2 2025 New
AYLA Ayala Pharmaceuticals, Inc.	$0	$0 100.0% of portfolio	0	Q2 2025 New
BEAM Beam Therapeutics Inc.	$1.15B	$0 100.0% of portfolio	0	Q2 2025 New
BGNE Bei Gene, Ltd.	$23.5B	$0 100.0% of portfolio	0	Q2 2025 New
BLTE Belite Bio, Inc	$1.63B	$0 100.0% of portfolio	0	Q2 2025 New
BYSI Beyond Spring Inc.	$67.3M	$0 100.0% of portfolio	0	Q2 2025 New
BCYC Bicycle Therapeutics PLC	$219M	$0 100.0% of portfolio	0	Q2 2025 New
TECH Bio Techne Corp	$2.1B	$0 100.0% of portfolio	0	Q2 2025 New
BCAB Bio Atla, Inc.	$16.7M	$0 100.0% of portfolio	0	Q2 2025 New
BCRX Biocryst Pharmaceuticals Inc	$1.54B	$0 100.0% of portfolio	0	Q2 2025 New
BMRN Biomarin Pharmaceutical Inc	$11B	$0 100.0% of portfolio	0	Q2 2025 New
BMEA Biomea Fusion, Inc.	$57.1M	$0 100.0% of portfolio	0	Q2 2025 New
BNTX Bio N Tech Se	$24.4B	$0 100.0% of portfolio	0	Q2 2025 New
BPTS Biophytis Sa	$115M	$0 100.0% of portfolio	0	Q2 2025 New
BRTX Bio Restorative Therapies, Inc.	$6.42M	$0 100.0% of portfolio	0	Q2 2025 New
BDTX Black Diamond Therapeutics, Inc.	$102M	$0 100.0% of portfolio	0	Q2 2025 New
BPMC Blueprint Medicines Corp	$7.73B	$0 100.0% of portfolio	0	Q2 2025 New
BBIO Bridge Bio Pharma, Inc.	$7.41B	$0 100.0% of portfolio	0	Q2 2025 New
CCCC C4 Therapeutics, Inc.	$127M	$0 100.0% of portfolio	0	Q2 2025 New
CABA Cabaletta Bio, Inc.	$41.8M	$0 100.0% of portfolio	0	Q2 2025 New
CANF Can Fite Bio Pharma Ltd.	$17.9M	$0 100.0% of portfolio	0	Q2 2025 New
CADL Candel Therapeutics, Inc.	$169M	$0 100.0% of portfolio	0	Q2 2025 New
CAPR Capricor Therapeutics, Inc.	$154M	$0 100.0% of portfolio	0	Q2 2025 New
CRDF Cardiff Oncology, Inc.	$89.3M	$0 100.0% of portfolio	0	Q2 2025 New
CRBU Caribou Biosciences, Inc.	$114M	$0 100.0% of portfolio	0	Q2 2025 New
CASI Casi Pharmaceuticals, Inc.	$31.4M	$0 100.0% of portfolio	0	Q2 2025 New
SAVA Cassava Sciences Inc	$91.4M	$0 100.0% of portfolio	0	Q2 2025 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.12B	$0 100.0% of portfolio	0	Q2 2025 New
CELC Celcuity Inc.	$783M	$0 100.0% of portfolio	0	Q2 2025 New
CLDX Celldex Therapeutics, Inc.	$1.03B	$0 100.0% of portfolio	0	Q2 2025 New
CLLS Cellectis S.A.	$117M	$0 100.0% of portfolio	0	Q2 2025 New
CELUW Celularity Inc Wt Exp 05/24/20	$0	$0 100.0% of portfolio	0	Q2 2025 New
CNTA Centessa Pharmaceuticals PLC	$1.58B	$0 100.0% of portfolio	0	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.